Guckel Denise, Farr Martin, Sommer Philipp, Sohns Christian
Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
Eur Heart J Case Rep. 2022 Feb 14;6(2):ytac030. doi: 10.1093/ehjcr/ytac030. eCollection 2022 Feb.
This case reviews the cardiac involvement of myotonic dystrophy type 2 in terms of ventricular arrhythmias (VAs) and individual myocardial scar formation as target for catheter ablation.
A 62-year-old woman with myotonic dystrophy type 2 and a severely reduced left ventricular ejection fraction (25%) presented with recurrent episodes of VAs and consecutive implantable cardioverter-defibrillator therapies. The patient already underwent two VA ablation attempts focusing on an ischaemia-related arrhythmia substrate in the left ventricle. The patient was scheduled for repeat ablation after the progression of coronary artery disease was ruled out. Interestingly bipolar voltage as well as activation mapping revealed an arrhythmia substrate along with the basal and inferior aspects of the right ventricle (RV). Catheter ablation of this scarred area in the RV resulted in specific termination of the VAs. Due to end-stage heart failure, key heart transplant criteria were met. The patient was evaluated for heart transplantation and added to the waiting list. Hitherto, no further VAs were documented during follow-up.
As these patients present with specific dystrophia-related arrhythmia substrates, we propose pre-procedural visualization of dystrophy-associated arrhythmia substrates using cardiac magnetic resonance imaging allowing for personalized ablation approaches in these patients.
本病例从室性心律失常(VAs)以及作为导管消融靶点的个体心肌瘢痕形成方面,对2型强直性肌营养不良的心脏受累情况进行了回顾。
一名62岁患有2型强直性肌营养不良且左心室射血分数严重降低(25%)的女性,出现反复发作的室性心律失常以及连续的植入式心律转复除颤器治疗。该患者已经针对左心室缺血相关心律失常基质进行了两次室性心律失常消融尝试。在排除冠状动脉疾病进展后,患者计划再次进行消融。有趣的是,双极电压以及激动标测显示右心室(RV)基底部和下壁存在心律失常基质。对右心室这个瘢痕区域进行导管消融导致室性心律失常特异性终止。由于终末期心力衰竭,符合心脏移植的关键标准。对该患者进行了心脏移植评估并列入等待名单。迄今为止,随访期间未记录到进一步的室性心律失常。
由于这些患者存在特定的营养不良相关心律失常基质,我们建议在术前使用心脏磁共振成像对营养不良相关心律失常基质进行可视化,以便对这些患者采用个性化消融方法。